FI49514C - Menetelmä farmaseuttisesti aktiivisten 11-asemaan substituoitujen 5,11 -dihydro-6H-pyrido(2,3-b)(1,4)bensodiatsepin-6-onien valmistamiseksi. - Google Patents

Menetelmä farmaseuttisesti aktiivisten 11-asemaan substituoitujen 5,11 -dihydro-6H-pyrido(2,3-b)(1,4)bensodiatsepin-6-onien valmistamiseksi.

Info

Publication number
FI49514C
FI49514C FI682573A FI257368A FI49514C FI 49514 C FI49514 C FI 49514C FI 682573 A FI682573 A FI 682573A FI 257368 A FI257368 A FI 257368A FI 49514 C FI49514 C FI 49514C
Authority
FI
Finland
Prior art keywords
benzodiazepin
pyrido
dihydro
ones
substituted
Prior art date
Application number
FI682573A
Other languages
English (en)
Swedish (sv)
Other versions
FI49514B (fi
Inventor
Guenther Schmidt
Guenther Engelhardt
Hans Machleidt
Karl Koenigsdorfer
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Application granted granted Critical
Publication of FI49514B publication Critical patent/FI49514B/fi
Publication of FI49514C publication Critical patent/FI49514C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI682573A 1966-10-31 1968-09-13 Menetelmä farmaseuttisesti aktiivisten 11-asemaan substituoitujen 5,11 -dihydro-6H-pyrido(2,3-b)(1,4)bensodiatsepin-6-onien valmistamiseksi. FI49514C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DET0032424 1966-10-31
DET0034793 1967-09-15

Publications (2)

Publication Number Publication Date
FI49514B FI49514B (fi) 1975-04-01
FI49514C true FI49514C (fi) 1975-07-10

Family

ID=26000257

Family Applications (1)

Application Number Title Priority Date Filing Date
FI682573A FI49514C (fi) 1966-10-31 1968-09-13 Menetelmä farmaseuttisesti aktiivisten 11-asemaan substituoitujen 5,11 -dihydro-6H-pyrido(2,3-b)(1,4)bensodiatsepin-6-onien valmistamiseksi.

Country Status (12)

Country Link
US (1) US3539554A (fi)
BE (1) BE720861A (fi)
CA (1) CA946843A (fi)
CH (1) CH491942A (fi)
DE (2) DE1620572B1 (fi)
DK (1) DK120158B (fi)
FI (1) FI49514C (fi)
FR (1) FR7081M (fi)
GB (1) GB1176867A (fi)
NL (2) NL6812503A (fi)
SE (1) SE338050B (fi)
YU (2) YU31963B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI50242C (fi) * 1969-07-18 1976-01-12 Thomae Gmbh Dr K Menetelmä valmistaa farmakologisesti aktiivisia uusia diallyyliaminoal kanoyylidibenso- tai pyridobenso-diatsepiineja ja niiden happoadditios uoloja.
GB2053187A (en) * 1979-07-09 1981-02-04 Grissmann Chem Ltd Process for preparing pyrenzepine
ATE103918T1 (de) * 1989-06-28 1994-04-15 Boehringer Ingelheim Pharma 5,11-dihydro-6h-dipyrido(3,2-b:2',3'e>(1,4>diazepin-6-one und -thione und ihre verwendung bei der aids-vorbeugung oder behandlung.
US5087625A (en) * 1990-10-19 1992-02-11 Boehringer Ingelheim Pharmaceuticals, Inc. Pyridodiazepines and their use in the prevention or treatment of HIV infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH438343A (de) * 1962-11-08 1967-06-30 Thomae Gmbh Dr K Verfahren zur Herstellung von 5,6-Dihydro-6-oxo-11H-pyrido (2,3-b) (1,4)-benzodiazepinen

Also Published As

Publication number Publication date
CA946843A (en) 1974-05-07
FR7081M (fi) 1969-06-30
YU31963B (en) 1974-02-28
YU35127B (en) 1980-09-25
CH491942A (de) 1970-06-15
DK120158B (da) 1971-04-19
DE1620572B1 (de) 1971-10-14
YU215068A (en) 1973-08-31
GB1176867A (en) 1970-01-07
YU40073A (en) 1980-03-15
BE720861A (fi) 1969-03-13
FI49514B (fi) 1975-04-01
US3539554A (en) 1970-11-10
NL6812503A (fi) 1969-03-18
DE1695903A1 (de) 1972-03-02
NL131929C (fi)
SE338050B (fi) 1971-08-30

Similar Documents

Publication Publication Date Title
FI49515C (fi) Menetelmä farmakologisesti vaikuttavien 11-asemaan substituoitujen 5,1 1-dihydro-6H-pyrido/2,3-b//1,4/bentsodiatsepiini-6-onien valmistamisek si.
FI49957C (fi) Menetelmä terapeuttisesti vaikuttavien oksiimieetterien valmistamiseks i.
IL29485A (en) Process for the preparation of 2,3,4,5-tetrahydro-1h-3-benzazepines
SE390969B (sv) Forfarande for framstellning av 1,2,3,4-tetrahydro-7-halogen-6-sulfamyl-4-kinazolinoner
FI49497C (fi) Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.
FI50707C (fi) Menetelmä uusien farmakologisesti vaikuttavien hydroksisykloheksyyliam iinien valmistamiseksi.
FI49720C (fi) Menetelmä terapeuttisesti vaikuttavien 2-metyyli-3-karbonihappoamidoki noksaliini-di-N-oksidien-(1,4) valmistamiseksi.
FI45966C (fi) Menetelmä kokkiostaattisesti aktiivisten 4-hydroksi-6,7-dialkoksi-3-ka rboalkoksikinoliinien valmistamiseksi.
FI44801C (fi) Menetelmä uusien, terapeuttisesti vaikuttavien, emäksisten eettereiden valmistamiseksi.
FI49718C (fi) Menetelmä terapeuttisesti vaikuttavien 2-halogeenimetyyli-3-karbonihap poamidokinoksaliini-di-N-oksidien-(1,4) valmistamiseksi.
FI49514C (fi) Menetelmä farmaseuttisesti aktiivisten 11-asemaan substituoitujen 5,11 -dihydro-6H-pyrido(2,3-b)(1,4)bensodiatsepin-6-onien valmistamiseksi.
FI50630C (fi) Menetelmä farmakologisesti vaikuttavien 2,3,4,4a-tetrahydro-10H-1,2-ok satsino (3,2-b) (1,3) bentsoksatsiini-10-onien valmistamiseksi.
IL37183A (en) Process for the preparation of 2,5-dichloro-4-alkylmercapto-phenols
FI51349C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 6,7-bentsomor faanien valmistamiseksi.
FI47347C (fi) Menetelmä terapeuttisesti vaikuttavien 5H-dibentso(a,d)syklohepteenijo hdannaisten valmistamiseksi.
FI47661C (fi) Menetelmä terapeuttisesti vaikuttavien bentsofuraanijohdannaisten valm istamiseksi.
FI46066C (fi) Analogiamenetelmä terapeuttisesti vaikuttavien N,N-dimetyyliamino-etyy li-14beta-hydroksi-5beta-pregn-20-eeni-21-karboksylaattien valmistamis eksi.
FI48732C (fi) Menetelmä farmakologisesti aktiivisten 3-substituoitu-amino-1,2,3,4-te trahydrokarbatsolien valmistamiseksi.
SE380531B (sv) Forfarande for framstellning av 13-alkyl-1,3,5(10),6,8,14-steroidhexaener
IL29620A (en) Process for the preparation of 1-n-butyl-2',6'-pipecoloxylidide
ES350001A0 (es) Procedimiento de preparacion de ftalazino-[2,3-b] ftalazina-5 (14h), 12(7h)-dionas.
FI49722C (fi) Menetelmä terapeuttisesti vaikuttavien 3-karbonihappoamidokinoksaliini -di-N-oksidien-(1,4) valmistamiseksi.
FI45172C (fi) Menetelmä 17alfa-asyylioksi-6-kloori-1,2alfa-metyleeni-21-fluori- 4,6- pregnadieenien valmistamiseksi.
FI48841C (fi) Menetelmä farmakologisesti aktiivisten 5-nitro-2-furfuryylideeniamino- oksatsolidinonien valmistamiseksi.
AU423344B2 (en) Process for the preparation of pharmaceutically active new guanidino-alkyl-cycloimines